The latest news from Maui Derm 2025 focused on psoriasis including abstracts, features, and helpful conference information.
Data from the Swiss Psoriasis Registry and the EuroGuiDerm guidelines highlight sex differences in psoriasis and the impact on health-related quality of life.
Geeta Yadav, MD, and colleagues used a Canadian Delphi consensus to produce guidelines to optimize psoriasis management in patients with skin of color.
Findings from the VISIBLE trial will help address gaps in psoriasis care for patients with skin of color and inform best practices to drive inclusive research.
The TELEPROM Psoriasis study highlights how telepharmacy and patient-reported outcomes improve the quality of life for patients with moderate-to-severe psoriasis.
On Tuesday, January 21, 2025, Joel Gelfand, MD, will join a panel of speakers to discuss the changing landscape of psoriasis and psoriatic arthritis.
Is there a session you'd like to see Physician's Weekly cover at Maui Derm?
On Tuesday January 21, 2025 Julie Harper, MD, will lead a discussion on clinical updates for WINLEVI (clascoterone) Cream 1%.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
